ICRF-159: Current status and clinical prospects

This publication has 18 references indexed in Scilit:

• Antimetastasis effect of two derivatives of epipodophyllotoxin in mice
  Published by Elsevier ,1976
• A Study of Antitumor (Phase II) and Immunosuppressive Effects of ICRF‐159 in Patients with Metastatic Melanoma
  The Journal of Clinical Pharmacology, 1976
• ICRF 159, (±) 1,2-di(3,5-dioxopiperazin-1-yl)propane NSC-129,943; Razoxane
  Cancer Treatment Reviews, 1976
• The bioavailability in man of ICRF-159 a new oral antineoplastic agent
  Journal of Pharmacy and Pharmacology, 1975
• Synergism of ICRF 159 and radiotherapy in treatment of experimental tumors
  Cancer, 1974
• Combined treatment of soft tissue and osteosarcomas by radiation and ICRF 159
  Cancer, 1974
• Mode of Action of the Cytostatic Agent ‘ICRF 159’
  Nature, 1970
• Biochemical studies on growth‐inhibitory bisdioxopiperazines. I. Effect on dna, rna and protein synthesis in mouse‐embryo fibroblasts
  International Journal of Cancer, 1970
• Antitumour Activity in a Series of bisDiketopiperazines
  Nature, 1969
• Preliminary Clinical Assessment of I.C.R.F. 159 in Acute Leukaemia and Lymphosarcoma
  BMJ, 1969